原发性肝癌患者血清HBV-DNA和HCV-RNA的含量分析
出处
《微循环学杂志》
2007年第3期72-72,74,共2页
Chinese Journal of Microcirculation
参考文献6
-
1高纪东,邵永孚,许杨,明利华,吴志远,刘国亭,王小红,王文红,冯晓丽,孙宗棠.中国北方肝细胞癌与乙肝病毒感染的紧密关联性[J].中华肝胆外科杂志,2004,10(6):363-365. 被引量：8
-
2Davila JA, Morgan RO, Shaib Y, et el. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a populationbased study. Gastroenterology.2004s127(4) :1 372-1 380.
-
3Hunt C,Mcgill J, Allen M, et al. Clinical relevance of hepatitis B viral mutations. Hepatology, 2000,31(5):1037-1044.
-
4Ryosuke M, Naoya K, Haruhiko Y,et al. Nucleotide change of codon 38 in the Ⅹ gene of hepatitis B virus genotype C is associated with an increased risk of hepatocellular carcinoma. Hepstology,2006, 45(6) :805-812.
-
5Iain HM, Diarmuid MM, Xiaoling J, et al. Molecular pathogenesis of hepatocellular carcinoma. Surgical Research, 2006, 136 (1): 125-135.
-
6Roberta P, Eric T,Ronnie TP. Molecular pathwaysin hepatoceliular carcinoma. Cancer Letters, 2006, 240(2) : 157- 169.
二级参考文献8
-
1Shibata Y, Nakata K, Tsuruta S, et al. Detection of hepatitis B virus X-region DNA in liver tissue from patients with hepatitis C virus-associated cirrhosis who subsequently developed hepatocellular carcinoma. Int J Oncol,1999,14:1153-1156.
-
2Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer,1999,80:827-841.
-
3Sun ZT, Ming LH, Zhu X, et al. Prevention and control of hepatitis B in China. J Med Virol,2002,67:447-450.
-
4Kew MC. The hepatitis B virus and hepatocellular carcinoma. Clin Liver Dis, 2000,4:257-268.
-
5Ming L, Thorgeirsson SS, Gail MH, et al. Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China. Hepatology,2002,36:1214-1220.
-
6Aubuchon JP, Sandler SG, Fang CT, et al. American Red Cross experience with routine testing for hepatitis B core antibody. Transfusion,1989,29:230-232.
-
7Yano M, Yatsuhashi H, Inoue O, et al. Epidemiology of hepatitis C virus in Japan: role in chronic liver disease and hepatocellular carcinoma. J Gastroenterol Hepatol,1991,6:31-35.
-
8张帆,朱源荣,孙宗棠.中国高发区肝细胞癌中HBVx基因的广泛存在及与p53基因249密码子高频率点突变的密切关联[J].中华肿瘤杂志,1998,20(1):18-21. 被引量：12
共引文献7
-
1李穗芬,谭奕洲,唐漾波,张惠忠,陈志浩.三种肝炎病毒在肝细胞癌组织及慢性肝炎肝组织中的表达[J].实用医技杂志,2005,12(06B):1567-1569. 被引量：1
-
2高应林,赵友云,王春香,乐惠荣.原发性肝细胞癌患者外周血单个核细胞中HBV-DNA含量检测的意义[J].现代肿瘤医学,2007,15(11):1634-1635. 被引量：2
-
3蒋丽琳.HCV与肝癌发病关系的研究进展[J].亚太传统医药,2008,4(9):125-126. 被引量：2
-
4孙爱武,陈园生,李黎,梁晓峰.乙型病毒性肝炎和原发性肝细胞癌[J].中国疫苗和免疫,2010,16(2):173-177. 被引量：13
-
5杜君,田萍,陈陶阳,吴健雄,王金兵,魏勇,王黎明,刘立国,季万盛,曲春枫.慢性乙肝病毒感染者进展为肝癌病程中血清循环免疫复合物的含量变化和意义[J].中华肿瘤杂志,2011,33(12):905-910. 被引量：2
-
6汪颖,吴志远,任书荣,魏勇,张昆,曲春枫.表达乙型肝炎病毒抗原的种植性肝脏肿瘤动物模型的建立[J].中华肿瘤杂志,2012,34(7):486-491.
-
7金昌男,林建军,沈锐潮.原发性肝癌64例HBV感染及癌旁组织病理检查分析[J].福建医药杂志,2012,34(6):56-57.
-
1张育锋,黄东平,黄炳坤.HCV-RNA及ALT、AST联合检测在丙肝患者诊断治疗中的应用研究[J].临床医学工程,2015,22(7):923-924. 被引量：4
-
2贾赞安,崔芳芳.丙型肝炎病毒感染者合并代谢综合征的相关研究[J].中国实用医药,2013,8(33):78-79. 被引量：1
-
3彭明喜,张哲,许德义,汤晓娴,张亚琴,董国飞,巩继勇.HCV感染者外周血CD4^+CD25^+Foxp3^+调节性T细胞的检测及意义[J].浙江检验医学,2009,0(2):38-40. 被引量：2
-
4谢志春,奥野裕康,秦雪,邬质彬.慢性肝炎及肝硬化患者抗-HCV的检测[J].广西医科大学学报,1995,12(4):591-592.
-
5覃益华.丙型肝炎患者自身抗体检测115例结果分析[J].医学信息（中旬刊）,2011,24(4):1292-1293. 被引量：5
-
6杨华,侯华嘉.各种献血员丙型肝炎病毒抗体的检测及其意义[J].广州医药,1997,28(5):57-59.
-
7熊春林,郭满盈,罗媛烨,杨海燕.丙肝抗体阳性者血清中HCV抗原的检测[J].实验与检验医学,2009,27(3):320-320. 被引量：13
-
8甘新宇,黄菲,杨洋.孵育时间对ELISA检测抗-HCV抗体结果影响的探讨[J].国际检验医学杂志,2013,34(B12):67-68.
-
9郭兰英,邹丹.医院常规就诊人群抗-HCV检测回顾性分析[J].标记免疫分析与临床,2010,17(5):331-332. 被引量：4
-
10公理,刁爱仁,赵志娥.27916名无偿献血者抗-HCV抗体情况的调查分析[J].疾病监测,2003,18(5):178-178.
